Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety, tolerability, and pharmacokinetics of ASCT-83 in healthy adults for neuropathic pain; recruitment status is NOT_YET_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• ASCT-83

Snippet

Sponsor: Alcamena Stem Cell Therapeutics | Conditions: Neuropathic Pain | Phase 1 | Status: NOT_YET_RECRUITING